)
Investor Relations
A Biotech Leader Driven by Our Promise
CSL is a global biotech leader. We conduct business in over 60 countries, with major facilities in Australia, Germany, Switzerland, the United Kingdom and the United States. With an unwavering focus on our promise to patients – to deliver life-saving and life-improving therapies that help many thousands of people live full lives – it is our dedicated management and employees that drive our performance.
-
US$45 billion
market capitalization
-
US$6.9+ billion
annual revenue
-
$1.3 billion
2017 Net Profit After Tax
Contact Investor Relations
Mark Dehring
Head of Investor Relations
45 Poplar Road, Parkville
Victoria 3052
Australia
Phone: +61 3 9389 3407
Bernard Ronchi
Senior Manager, Investor Relations
45 Poplar Road, Parkville
Victoria 3052
Australia
Phone: +61 3 9389 3470
Get our latest news in your inbox
Thanks!
Thank you for subscribing
to the CSL newsletter